Vertex Pharmaceuticals CEO Reshma Kewalramani Sells $6.31 Million of Stock
Vertex Pharmaceuticals Chief Executive and President Reshma Kewalramani sold $6.31 million of Vertex stock on Friday, Nov. 6, according to a Form 4 filed Tuesday.
Kewalramani, who also sits on the board, sold 11,866 shares at a reported price of $531.53 a share, for a total of $6,307,135.
The sale was made under a company-approved Rule 10b5-1 trading plan she entered into on Aug. 5, 2026, the filing says. Such plans set the terms of future trades in advance.
What she holds now
After the sale, Kewalramani directly owned 86,471 Vertex shares, according to the filing.
By the numbers
- Shares sold: 11,866
- Sale price: $531.53
- Sale value: $6,307,135
- Trade date: Nov. 6, 2026
- Trading plan adopted: Aug. 5, 2026
- Shares held directly afterward: 86,471
Sources
- Form 4, Reshma Kewalramani, Vertex Pharmaceuticals Incorporated, filed Nov. 10, 2026, accession 0000875320-26-000293
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence. SI may make mistakes.